The company has announced that its new investigational device exemption will be used to launch a pivotal trial of its ...
R3 Vascular announced today that the FDA granted investigational device exemption (IDE) to evaluate its drug-eluting ...
US-based Envoy Medical has received approval from the US Food and Drug Administration (FDA) for its investigational device ...
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
The result calls into question the prospects of FDA approval for the Acurate neo2 valve, which is already in use globally.
The trial is anticipated to commence in Q1 2025 and will enrol 264 subjects at up to 60 clinical sites worldwide.
The Acclaim® Fully ImplantedCochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients ...
Jupiter Endovascular, Inc. announced that the first patient has been treated in the SPIRARE II United States pivotal study of ...
The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...
CytexOrtho has earned FDA approval to begin a clinical trial evaluating the safety and efficacy of its absorbable hip implant in human patients, according to an Oct. 29 report from Mass Device. The ...